|
Re: HER2 learning more is it a bad thing?
I was considered in a "grey area" when it came time to decide on treatment. My cancer was "small" and I was node negative. I sought a few opinions. One was with a highly regarded consultant. She felt I needed NO further treatment based on my statistics. Not even an AI! Long story short, I chose to go the route of chemo and Herceptin anyhow. Partly out of fear (not a good bases for a decision!) and partly out of feeling I needed to do MORE. And so I would not feel regret later (I am big on regrets!). I feel you are in that same place. Your oncologists reasoning may be sound and logical, but sometimes logic is not a factor when one is the patient!
I hope you can obtain a second opinion and also have a good conversation with your onc. And mostly I hope you find peace of mind. Keep the faith.
__________________
Bonnie
Post menopause
May 2007 Core biopsy, Rt breast
ER+, Pr-, HER2 +++, Grade 3
Ki-67: 90%
"suspicious area" left breast
Bilateral mastectomy, (NED on left) May 2007
Sentinel Node Neg
Stage 1, DCIS with microinvasion, 3 mm, mostly removed during the biopsy....
Femara (discontinued 7/07) Resumed 10/07
OncoType score 36 (July 07)
Began THC 7/26/07 (d/c taxol and carboplatin 10/07)
Began Herceptin alone 10/07
Finished Herceptin July /08
D/C Femara 4/10 (joint pain/trigger thumb!)
5/10 mistakenly dx with lung cancer. Middle rt lobe removed!
Aromasin started 5/10
|